Endo has agreed to pay states $450 million over 10 years to support treatment and prevention of opioid use problems. ... Endo files for bankruptcy and inks $450M settlement.

MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has taken a significant step towards listing its shares on the New York Stock Exchange (NYSE) by filing a registration statement with the U.S. Securities ...

These filings pave the way for Endo to promptly emerge from Chapter 11 with a strengthened balance sheet and to advance its ongoing business transformation, the company said.

Endo files for Chapter 11 bankruptcy . Endo and certain of its subsidiaries initiated voluntary prearranged Chapter 11 proceedings in New York. Sandra Levy. 8/29/2022.

Endo, Inc. (OTCQX: NDOI) ("Endo" or the "Company"), a diversified specialty pharmaceutical company transforming insights into life-enhancing therapies, today announced that it has publicly filed a ...

Endo files for bankruptcy as U.S. opioid litigation drags. By Reuters. August 17, 2022 5:00 PM UTC Updated August 17, 2022 Item 1 of 2 A full syringe, empty syringe and spoon sit ...

Endo International became the latest pharmaceutical company to file for bankruptcy under the weight of lawsuits alleging it played a role in fueling the opioid crisis.

MALVERN, Pa., July 12, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) ("Endo" or the "Company"), a diversified specialty pharmaceutical company transforming insights into life-enhancing therapies ...

Endo Files Registration Statement with SEC, Advancing Planned Move to NYSE. PR Newswire . Fri, Jul 12, 2024, 9:22 AM 3 min read. In This Article: NDOI .